What they do
DayTwo uses gut microbiome profiling and predictive algorithms to deliver highly personalized nutritional recommendations. Designed to control blood sugar spikes and improve metabolic clinical outcomes, the platform is purchased primarily by employers and health plans.
The record
- Vertical
- Metabolic Health
- Sub-segment
- Personalised metabolic nutrition
- Product type
- Diagnostics
- Stage
- Series C+
- Headquarters
- Walnut Creek, USA
- Region
- North America
- Founded
- 2015
- Total funding
- $85M raised
Notable investors: Cathay Innovation, aMoon Venture Partners, Marius Nacht.